Clinical predictors of COVID19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China

J Liu, Z Liu, W Jiang, J Wang, M Zhu… - The Clinical …, 2021 - Wiley Online Library
… A total of 214 hospitalised patients diagnosed with COVID-19 were enrolled in this study,
including 62 (29.0%) moderate, 94 (43.9%) severe and 58 (27.1%) critically ill cases, …

Risk factors for disease progression in COVID-19 patients

MC Chang, YK Park, BO Kim, D Park - BMC infectious diseases, 2020 - Springer
COVID-19 patients with initial asymptomatic or mild stage who were transferred to a specialized
infectious disease hospital due to COVID-19 progression to … University Hospital and the …

Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study

W Hou, W Zhang, R Jin, L Liang, B Xu, Z Hu - Infectious diseases, 2020 - Taylor & Francis
… factors for disease progression in patients who were hospitalized with COVID-19 in Beijing.
… with higher odds of in-hospital disease progression. Additionally, more comorbidities, …

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan

M Terada, H Ohtsu, S Saito, K Hayakawa, S Tsuzuki… - BMJ open, 2021 - bmjopen.bmj.com
… This study investigated the disease progression of COVID-19, by comparing the risk factors
on three points: early severity, worst severity throughout hospitalisation and fatality, whereas …

Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China

J Zhang, M Yu, S Tong, LY Liu, LV Tang - Journal of Clinical Virology, 2020 - Elsevier
… from 111 hospitalized patients with laboratory-confirmed COVID-19 in Union Hospital. The
… We report here a cohort of 111 laboratory-confirmed hospitalized patients with COVID-19. In …

Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
… Although Hcy is an effective cardiovascular risk biomarker, and the cardiovascular complications
are critical in hospitalized COVID-19 patients, this parameter has not been adopted and …

Clinical manifestation and disease progression in COVID-19 infection

PH Tsai, WY Lai, YY Lin, YH Luo, YT Lin… - Journal of the …, 2021 - journals.lww.com
COVID-19 patients are shown in the Figure. The abnormalities of glycemic metabolism in
hospitalized patients with COVID-19 … that 6.4% of hospitalized patients had ketosis without the …

Could we predict the prognosis of the COVID19 disease?

CA Tahtasakal, A Oncul, DY Sevgi… - Journal of Medical …, 2021 - Wiley Online Library
… We aimed to predict poor prognosis among severe patients to lead early intervention. … 570
hospitalized patients were analyzed retrospectively in our single-centered trial and 36 patients

Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?

J Zhang, S Lu, X Wang, X Jia, J Li, H Lei, Z Liu, F Liao… - Heart, 2020 - heart.bmj.com
… Multivariable logistic regression analysis revealed that CVD (OR: 2.735 (95% CI 1.495 to
5.003), p=0.001) was associated with critical COVID-19 condition, while patients with coronary …

COVID-19 disease severity risk factors for pediatric patients in Italy

…, A Villani, P Pezzotti, COVID-19 Working Group - …, 2020 - publications.aap.org
… infection or with an epidemiological link (close contact with a confirmed COVID-19 case
in … where ongoing COVID-19 transmission has been confirmed), hospitalized patients with …